170 related articles for article (PubMed ID: 31573846)
1. The antagonist of CXCR1 and CXCR2 protects
Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
[TBL] [Abstract][Full Text] [Related]
2. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
Li F; Zhang X; Gordon JR
Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
[TBL] [Abstract][Full Text] [Related]
3. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
4. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
5. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
[TBL] [Abstract][Full Text] [Related]
6. CXCR1/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy.
Ye Y; Zhang Y; Wang B; Walana W; Wei J; Gordon JR; Li F
Biomed Pharmacother; 2018 Nov; 107():1142-1150. PubMed ID: 30257327
[TBL] [Abstract][Full Text] [Related]
7. Porcine CXCR1/2 antagonist CXCL8
Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W
Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368
[TBL] [Abstract][Full Text] [Related]
8. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
[TBL] [Abstract][Full Text] [Related]
9. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
[TBL] [Abstract][Full Text] [Related]
10. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
[TBL] [Abstract][Full Text] [Related]
11. CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose-Induced Mesangial Injury.
Cui S; Zhu Y; Du J; Khan MN; Wang B; Wei J; Cheng JW; Gordon JR; Mu Y; Li F
Endocrinology; 2017 Jun; 158(6):1671-1684. PubMed ID: 28387853
[TBL] [Abstract][Full Text] [Related]
12. Combined CXCR1/CXCR2 antagonism decreases radiation-induced alveolitis in the mouse.
Fox J; Gordon JR; Haston CK
Radiat Res; 2011 May; 175(5):657-64. PubMed ID: 21342009
[TBL] [Abstract][Full Text] [Related]
13. CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung inflammation in swine barn dust-instilled mice.
Schneberger D; Gordon JR; DeVasure JM; Boten JA; Heires AJ; Romberger DJ; Wyatt TA
Pulm Pharmacol Ther; 2015 Apr; 31():55-62. PubMed ID: 25681618
[TBL] [Abstract][Full Text] [Related]
14. IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis.
Walana W; Ye Y; Li M; Wang J; Wang B; Cheng JW; Gordon JR; Li F
Biomed Pharmacother; 2018 Jul; 103():253-261. PubMed ID: 29655167
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
[TBL] [Abstract][Full Text] [Related]
16. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
Russo RC; Garcia CC; Teixeira MM; Amaral FA
Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
[TBL] [Abstract][Full Text] [Related]
17. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
18. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.
Bertini R; Barcelos LS; Beccari AR; Cavalieri B; Moriconi A; Bizzarri C; Di Benedetto P; Di Giacinto C; Gloaguen I; Galliera E; Corsi MM; Russo RC; Andrade SP; Cesta MC; Nano G; Aramini A; Cutrin JC; Locati M; Allegretti M; Teixeira MM
Br J Pharmacol; 2012 Jan; 165(2):436-54. PubMed ID: 21718305
[TBL] [Abstract][Full Text] [Related]
19. IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes.
Walana W; Wang JJ; Yabasin IB; Ntim M; Kampo S; Al-Azab M; Elkhider A; Dogkotenge Kuugbee E; Cheng JW; Gordon JR; Li F
Hum Immunol; 2018 Nov; 79(11):809-816. PubMed ID: 30125599
[TBL] [Abstract][Full Text] [Related]
20. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
Zaslaver A; Feniger-Barish R; Ben-Baruch A
J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]